SA
GMAB logo
Genmab A/S(GMAB)
Closing price · checked 8:25 PM ETAbout this dataData status
$50.60▼-0.75 (-1.46%)
Extended:$50.02-0.58 (-1.15%)· 8:25 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Genmab A/S (GMAB)

Common Stock

$10.00M

Quarterly · Period ending: · USD

GMAB logo

GMAB Common Stock

Latest reported$9.98M
GMAB FY Common Stock ($22.72M → $9.98M)
Powered by
High-resolution chart · PNG

What is common stock?

Par value of issued common shares.

GMAB common stock history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Genmab A/S Common Stock — Annual fiscal periods (USD)
Period endingCommon Stock (USD)Change
9,977,184−84.88%
66,000,0000.00%
66,000,0000.00%
66,000,0000.00%
66,000,0000.00%
66,000,000+1.54%
65,000,000+5.69%
61,498,000+0.51%
61,186,000+1.39%
60,350,000+1.38%
59,531,000+4.50%
56,967,000+10.07%
51,756,000+2.88%
50,308,000+12.03%
44,907,0000.00%
44,907,0000.00%
44,907,000+0.04%
44,889,000+0.83%
44,520,000+12.29%
39,648,000+19.75%
33,108,000+11.28%
29,752,000+29.46%
22,981,000+1.16%
22,717,000—

Frequently asked questions: GMAB common stock

What is Genmab A/S (GMAB)'s current common stock?

Genmab A/S (GMAB)'s latest reported common stock (Quarterly) is $10.00M as of Sep 30, 2026. Par value of issued common shares.

How much historical common stock data is available for GMAB?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Genmab A/S (GMAB)'s common stock, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GMAB's common stock to peers or set an alert?

You can open GMAB's common stock in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GMAB delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.